Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1380004.RAPskf3WKBbXjb2RButhFvlQ14mSSnr3-H_qacQsxB1fM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1380004.RAPskf3WKBbXjb2RButhFvlQ14mSSnr3-H_qacQsxB1fM130_assertion type Assertion NP1380004.RAPskf3WKBbXjb2RButhFvlQ14mSSnr3-H_qacQsxB1fM130_head.
- NP1380004.RAPskf3WKBbXjb2RButhFvlQ14mSSnr3-H_qacQsxB1fM130_assertion description "[The proportion of individuals with innate slow mEPHX activity (homozygotes) was significantly higher in both the COPD group and the emphysema group than in the control group (COPD 13 [19%] vs control 13 [6%]; emphysema 21 [22%] vs 13 [6%]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1380004.RAPskf3WKBbXjb2RButhFvlQ14mSSnr3-H_qacQsxB1fM130_provenance.
- NP1380004.RAPskf3WKBbXjb2RButhFvlQ14mSSnr3-H_qacQsxB1fM130_assertion evidence source_evidence_literature NP1380004.RAPskf3WKBbXjb2RButhFvlQ14mSSnr3-H_qacQsxB1fM130_provenance.
- NP1380004.RAPskf3WKBbXjb2RButhFvlQ14mSSnr3-H_qacQsxB1fM130_assertion SIO_000772 9288046 NP1380004.RAPskf3WKBbXjb2RButhFvlQ14mSSnr3-H_qacQsxB1fM130_provenance.
- NP1380004.RAPskf3WKBbXjb2RButhFvlQ14mSSnr3-H_qacQsxB1fM130_assertion wasDerivedFrom befree-2016 NP1380004.RAPskf3WKBbXjb2RButhFvlQ14mSSnr3-H_qacQsxB1fM130_provenance.
- NP1380004.RAPskf3WKBbXjb2RButhFvlQ14mSSnr3-H_qacQsxB1fM130_assertion wasGeneratedBy ECO_0000203 NP1380004.RAPskf3WKBbXjb2RButhFvlQ14mSSnr3-H_qacQsxB1fM130_provenance.